Challenges in the evaluation and management of radioactive iodine-refractory differentiated thyroid cancer

Nucl Med Commun. 2022 Jul 1;43(7):743-745. doi: 10.1097/MNM.0000000000001568. Epub 2022 Apr 19.

Authors

Matthew T Genco¹, Abid Yaqub, Suman Jana

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

PMID: 35438680
DOI: 10.1097/MNM.0000000000001568

No abstract available

Publication types

Editorial

MeSH terms

Adenocarcinoma*
Humans
Iodine Radioisotopes / therapeutic use
Protein Kinase Inhibitors
Thyroid Neoplasms* / diagnostic imaging
Thyroid Neoplasms* / radiotherapy

Substances

Iodine Radioisotopes
Protein Kinase Inhibitors